| |
Prospectus Supplement
|
| ||||||
| | | | | | S-ii | | | |
| | | | | | S-1 | | | |
| | | | | | S-8 | | | |
| | | | | | S-16 | | | |
| | | | | | S-18 | | | |
| | | | | | S-19 | | | |
| | | | | | S-22 | | | |
| | | | | | S-23 | | | |
| | | | | | S-57 | | | |
| | | | | | S-58 | | | |
| | | | | | S-66 | | | |
| | | | | | S-67 | | | |
| | | | | | S-73 | | | |
| | | | | | S-73 | | | |
| | | | | | S-74 | | | |
| | | | | | S-74 | | | |
| |
Prospectus
|
| ||||||
| | | | | | 1 | | | |
| | | | | | 2 | | | |
| | | | | | 5 | | | |
| | | | | | 6 | | | |
| | | | | | 7 | | | |
| | | | | | 8 | | | |
| | | | | | 10 | | | |
| | | | | | 17 | | | |
| | | | | | 21 | | | |
| | | | | | 22 | | | |
| | | | | | 22 | | | |
| | | |
Fiscal year
|
| |||||||||||||||||||||||||||
| | | |
2018
|
| |
2019
|
| |
2020
|
| |
1Q 2020
|
| |
1Q 2021
|
| |||||||||||||||
|
Cash flow from operations(1)
|
| | | | 291 | | | | | | 219 | | | | | | 3 | | | | | | (33) | | | | | | 22 | | |
|
Capital expenditures/investments
|
| | | | 128 | | | | | | 99 | | | | | | 50 | | | | | | 16 | | | | | | 8 | | |
|
Free cash flow (non-GAAP)
|
| | | | 163 | | | | | | 119 | | | | | | (47) | | | | | | (49) | | | | | | 13 | | |
| | | |
Fiscal Year
|
| |||||||||||||||||||||||||||
| | | |
2018
|
| |
2019
|
| |
2020
|
| |
1Q 2020
|
| |
1Q 2021
|
| |||||||||||||||
|
Net Income (GAAP)
|
| | | | 99 | | | | | | 127 | | | | | | (277) | | | | | | (136) | | | | | | (1) | | |
|
Tax expense
|
| | | | 8 | | | | | | 13 | | | | | | (103) | | | | | | (55) | | | | | | 2 | | |
|
Interest & other expense, net
|
| | | | 7 | | | | | | 2 | | | | | | 9 | | | | | | 2 | | | | | | 3 | | |
|
Depreciation & amortization expense
|
| | | | 96 | | | | | | 88 | | | | | | 91 | | | | | | 24 | | | | | | 22 | | |
|
Gain on investments in unconsolidated affiliates
|
| | | | 5 | | | | | | (39) | | | | | | — | | | | | | — | | | | | | — | | |
|
Dividends on Series A preferred stock
|
| | | | — | | | | | | — | | | | | | 13 | | | | | | — | | | | | | 5 | | |
|
Direct & incremental Series A preferred stock issuance costs
|
| | | | — | | | | | | — | | | | | | 10 | | | | | | — | | | | | | — | | |
|
EBITDA (non-GAAP)
|
| | | | 215 | | | | | | 192 | | | | | | (256) | | | | | | (166) | | | | | | 31 | | |
|
Impairment of assets and lease terminations
|
| | | | 18 | | | | | | 18 | | | | | | 219 | | | | | | 192 | | | | | | 1 | | |
|
Acquisition-related costs
|
| | | | — | | | | | | 5 | | | | | | 3 | | | | | | 1 | | | | | | — | | |
|
Acquisition-related contingent consideration and amortization expense
|
| | | | — | | | | | | 1 | | | | | | (4) | | | | | | (4) | | | | | | 1 | | |
|
COVID-19 related costs
|
| | | | — | | | | | | — | | | | | | 23 | | | | | | 3 | | | | | | 5 | | |
|
Adjusted EBITDA (non-GAAP)
|
| | | | 233 | | | | | | 216 | | | | | | (15) | | | | | | 25 | | | | | | 38 | | |
| | | |
As of March 30, 2021
|
| |||||||||||||||||||||
| | | |
Actual
|
| |
As adjusted
|
| |
As further
adjusted |
| |
Pro forma
as further adjusted |
| ||||||||||||
| | | |
(In thousands, except share and per share data)
|
| |||||||||||||||||||||
|
Cash and cash equivalents
|
| | | $ | 181,345 | | | | | $ | | | | | $ | | | | | $ | | | |||
| Debt: | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Revolving credit facility(1)(2)
|
| | | $ | 280,000 | | | | | $ | 280,000 | | | | | $ | 280,000 | | | | | $ | 280,000 | | |
|
Principal amount of % convertible senior notes due 2026 we are offering(3)
|
| | | | — | | | | | | 300,000 | | | | | | 300,000 | | | | | | 300,000 | | |
|
Total debt
|
| | | | 280,000 | | | | | | 580,000 | | | | | | 580,000 | | | | | | 580,000 | | |
|
Series A convertible preferred stock, $0.01 par value per share; 200,000 shares authorized, 200,000 shares issued and outstanding, actual, as adjusted and as further adjusted; no shares issued and outstanding, pro forma as further adjusted
|
| | | | 213,485 | | | | | | 213,485 | | | | | | 213,485 | | | | | | — | | |
| Stockholders’ equity: | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Preferred stock, $0.01 par value per share, other
than Series A convertible preferred stock; 4,800,000 shares authorized, no shares issued and outstanding, actual, as adjusted, as further adjusted and pro forma as further adjusted |
| | | | — | | | | | | — | | | | | | — | | | | | | — | | |
|
Common stock, $0.01 par value per share; 250,000,000 shares authorized; 99,508,470 shares outstanding, actual and as adjusted; shares outstanding, as further adjusted; shares outstanding, pro forma as further adjusted(4)
|
| | | | 995 | | | | | | 995 | | | | | | | | | | | | | | |
|
Additional paid-in capital(3)
|
| | | | 904,045 | | | | | | 904,045 | | | | | | | | | | | | | | |
|
Retained earnings(5)
|
| | | | 1,114,047 | | | | | | 1,114,047 | | | | | | 1,114,047 | | | | | | 1,114,047 | | |
|
Treasury stock, 53,101,293 shares at cost, actual, as adjusted, as further adjusted and pro forma as further adjusted
|
| | | | (1,700,700) | | | | | | (1,700,700) | | | | | | (1,700,700) | | | | | | (1,700,700) | | |
|
Accumulated other comprehensive loss
|
| | | | (1,873) | | | | | | (1,873) | | | | | | (1,873) | | | | | | (1,873) | | |
|
Total stockholders’ equity(3)(5)
|
| | | | 316,514 | | | | | | 316,514 | | | | | | | | | | | | | | |
|
Total capitalization(3)(5)
|
| | | $ | 809,999 | | | | | $ | 1,109,999 | | | | | $ | | | | | $ | | | | |
|
CR0
|
=
|
the conversion rate in effect immediately before the open of business on the ex-dividend date for such dividend or distribution, or immediately before the open of business on the effective date of such stock split or stock combination, as applicable; |
|
CR1
|
=
|
the conversion rate in effect immediately after the open of business on such ex-dividend date or effective date, as applicable; |
|
OS0
|
=
|
the number of shares of our common stock outstanding immediately before the open of business on such ex-dividend date or effective date, as applicable, without giving effect to such dividend, distribution, stock split or stock combination; and |
|
OS1
|
=
|
the number of shares of our common stock outstanding immediately after giving effect to such dividend, distribution, stock split or stock combination. |
|
CR0
|
=
|
the conversion rate in effect immediately before the open of business on the ex-dividend date for such distribution; |
|
CR1
|
=
|
the conversion rate in effect immediately after the open of business on such ex-dividend date; |
|
OS
|
=
|
the number of shares of our common stock outstanding immediately before the open of business on such ex-dividend date; |
|
X
|
=
|
the total number of shares of our common stock issuable pursuant to such rights, options or warrants; and |
|
Y
|
=
|
a number of shares of our common stock obtained by dividing (x) the aggregate price payable to exercise such rights, options or warrants by (y) the average of the last reported sale prices per share of our common stock for the 10 consecutive trading days ending on, and including, the trading day immediately before the date such distribution is announced. |
|
CR0
|
=
|
the conversion rate in effect immediately before the open of business on the ex-dividend date for such distribution; |
|
CR1
|
=
|
the conversion rate in effect immediately after the open of business on such ex-dividend date; |
|
SP
|
=
|
the average of the last reported sale prices per share of our common stock for the 10 consecutive trading days ending on, and including, the trading day immediately before such ex-dividend date; and |
|
FMV
|
=
|
the fair market value (as determined by us in good faith and in a commercially reasonable manner), as of such ex-dividend date, of the shares of capital stock, evidences of indebtedness, assets, property, rights, options or warrants distributed per share of our common stock pursuant to such distribution. |
|
CR0
|
=
|
the conversion rate in effect immediately before the close of business on the last trading day of the “spin-off valuation period” (as defined below) for such spin-off; |
|
CR1
|
=
|
the conversion rate in effect immediately after the close of business on the last trading day of the spin-off valuation period; |
|
FMV
|
=
|
the product of (x) the average of the last reported sale prices per share or unit of the capital stock or equity interests distributed in such spin-off over the 10 consecutive trading day period (the “spin-off valuation period”) beginning on, and including, the ex-dividend date for such spin-off (such average to be determined as if references to our common stock in the definitions of “last reported sale price,” “trading day” and “market disruption event” were instead references to such capital stock or equity interests); and (y) the number of shares or units of such capital stock or equity interests distributed per share of our common stock in such spin-off; and |
|
SP
|
=
|
the average of the last reported sale prices per share of our common stock for each trading day in the spin-off valuation period. |
|
CR0
|
=
|
the conversion rate in effect immediately before the open of business on the ex-dividend date for such dividend or distribution; |
|
CR1
|
=
|
the conversion rate in effect immediately after the open of business on such ex-dividend date; |
|
SP
|
=
|
the last reported sale price per share of our common stock on the trading day immediately before such ex-dividend date; and |
|
D
|
=
|
the cash amount distributed per share of our common stock in such dividend or distribution. |
|
CR0
|
=
|
the conversion rate in effect immediately before the close of business on the last trading day of the “tender/exchange offer valuation period” (as defined below) for such tender or exchange offer; |
|
CR1
|
=
|
the conversion rate in effect immediately after the close of business on the last trading day of the tender/exchange offer valuation period; |
|
AC
|
=
|
the aggregate value (determined as of the time (the “expiration time”) such tender or exchange offer expires by us in good faith and in a commercially reasonable manner) of all cash and other consideration paid for shares of our common stock purchased or exchanged in such tender or exchange offer; |
|
OS0
|
=
|
the number of shares of our common stock outstanding immediately before the expiration time (including all shares of our common stock accepted for purchase or exchange in such tender or exchange offer); |
|
OS1
|
=
|
the number of shares of our common stock outstanding immediately after the expiration time (excluding all shares of our common stock accepted for purchase or exchange in such tender or exchange offer); and |
|
SP
|
=
|
the average of the last reported sale prices per share of our common stock over the 10 consecutive trading day period (the “tender/exchange offer valuation period”) beginning on, and including, the trading day immediately after the expiration date; |
|
Make-Whole Fundamental
Change Effective Date |
| |
Stock Price
|
| |||||||||||||||||||||
| |
$
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
| ||
|
, 2021
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
|
June 15, 2022
|
| | | | | | | | | | | | | | | | | | | | | | | | |
|
June 15, 2023
|
| | | | | | | | | | | | | | | | | | | | | | | | |
|
June 15, 2024
|
| | | | | | | | | | | | | | | | | | | | | | | | |
|
June 15, 2025
|
| | | | | | | | | | | | | | | | | | | | | | | | |
|
June 15, 2026
|
| | | | | | | | | | | | | | | | | | | | | | | | |
|
Underwriter
|
| |
Principal
Amount of Notes |
| |||
|
J.P Morgan Securities LLC
|
| | | $ | | | |
|
BNP Paribas Corp.
|
| | | | | | |
|
BofA Securities, Inc.
|
| | | | | | |
|
Wells Fargo Securities, LLC
|
| | | | | | |
|
Total
|
| | | $ | 300,000,000 | | |
| | | |
Paid by The Cheesecake
Factory Incorporated |
| |||||||||
| | | |
No Exercise
|
| |
Full Exercise
|
| ||||||
| | | |
|
| |
|
| ||||||
|
Per Note
|
| | | | % | | | | | | % | | |
|
Total
|
| | | $ | | | | | $ | | | ||
| | | | | | 1 | | | |
| | | | | | 2 | | | |
| | | | | | 5 | | | |
| | | | | | 6 | | | |
| | | | | | 7 | | | |
| | | | | | 8 | | | |
| | | | | | 10 | | | |
| | | | | | 17 | | | |
| | | | | | 21 | | | |
| | | | | | 22 | | | |
| | | | | | 22 | | |